A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Is a genotype-guided therapy the optimal strategy to personalize anti-thrombotic management in patients with acute coronary syndrome?
2022
This commentary refers to 'Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum', by T. Lüscher et al., https:// doi.org/10.1093/eurheartj/ehab642.
doi:10.1093/eurheartj/ehac219
pmid:35678582
fatcat:lxrmxdsmm5czvafbdf677fk2ta